Zeile 45: |
Zeile 45: |
| *Gansauge F, Ramadani M, Pressmar J, Gansauge S, Muehling B, Stecker K, et al. NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial. Langenbecks Arch Surg. 2002;386:570–4. DOI 10.1007/s00423-001-0267-5 | | *Gansauge F, Ramadani M, Pressmar J, Gansauge S, Muehling B, Stecker K, et al. NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial. Langenbecks Arch Surg. 2002;386:570–4. DOI 10.1007/s00423-001-0267-5 |
| *Habermehl D, Kammerer B, Handrick R, Eldh T, Gruber C, Cordes N, Daniel PT, Plasswilm L, Bamberg M, Belka C, Jendrossek V. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway. BMC Cancer. 2006 Jan 17;6:14. | | *Habermehl D, Kammerer B, Handrick R, Eldh T, Gruber C, Cordes N, Daniel PT, Plasswilm L, Bamberg M, Belka C, Jendrossek V. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway. BMC Cancer. 2006 Jan 17;6:14. |
| + | *Bondar GV, Borota AV, Yakovets YI, Zolotukhin SE: Comparative evaluation of the complex treatment of rectal cancer patients (chemotherapy and X-ray therapy, Ukrain monotherapy). Drugs under experimental and clinical research 1998, 24(5-6):221-226. |
| + | *Cordes N, Plasswilm L, Bamberg M, Rodemann HP: Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation. International journal of radiation biology 2002, 78(1):17-27. |
| + | *Lanvers-Kaminsky C, Nolting DM, Koster J, Schroder A, Sandkotter J, Boos J: In-vitro toxicity of Ukrain against human Ewing tumor cell lines. Anti-cancer drugs 2006, 17(9):1025-1030. |
| *Falsche Hoffnungen, Der Spiegel Nr. 39 vom 22.9.2008 | | *Falsche Hoffnungen, Der Spiegel Nr. 39 vom 22.9.2008 |
| | | |